Health
Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection? – News-Medical.Net
A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.
The end of the ongoing coronavirus disease 2019 (COVID-19) pandemic may be in sight, with several countries having rolled out vaccination programs against the causative pathogen: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These campaigns aim to induce population immunity rapidly.
A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.
However, as new variants continue to emerge,…
Continue Reading
